Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands

(2020) Avinash G Dinmohamed et al.   LANCET ONCOLOGY

Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus

(2020) G. Curigliano et al.   ANNALS OF ONCOLOGY

Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands

(2020) E. Heeg et al.   BREAST CANCER RESEARCH AND TREATMENT

Impact of the COVID-19 pandemic on surgical breast cancer care in the Netherlands: a multicentre retrospective cohort study.

(2020) M.D. Filipe et al.   Clinical Breast Cancer

Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic

(2020) Mitch Dowsett et al.   npj Breast Cancer

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer

(2020) Evandro de Azambuja et al.   ESMO Open

Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer

(2019) William H. Ward et al.   ANNALS OF SURGICAL ONCOLOGY

A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers

(2018) Claudia J. C. Meurs et al.   BRITISH JOURNAL OF CANCER

Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit

(2018) Pauline E.R. Spronk et al.   EJSO